PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 112 filers reported holding PROVENTION BIO INC in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,687,000 | +128.0% | 70,000 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $740,000 | +134.9% | 70,000 | 0.0% | 0.00% | – |
| Q3 2022 | $315,000 | +12.5% | 70,000 | 0.0% | 0.00% | – |
| Q2 2022 | $280,000 | -45.3% | 70,000 | 0.0% | 0.00% | – |
| Q1 2022 | $512,000 | +30.3% | 70,000 | 0.0% | 0.00% | – |
| Q4 2021 | $393,000 | -12.3% | 70,000 | 0.0% | 0.00% | – |
| Q3 2021 | $448,000 | -24.1% | 70,000 | 0.0% | 0.00% | – |
| Q2 2021 | $590,000 | -19.7% | 70,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $735,000 | -38.0% | 70,000 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,186,000 | +32.1% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $898,000 | -9.1% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $988,000 | +39.9% | 70,000 | -8.8% | 0.00% | +100.0% |
| Q1 2020 | $706,000 | -32.3% | 76,725 | +9.6% | 0.00% | 0.0% |
| Q4 2019 | $1,043,000 | +118.2% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $478,000 | -81.2% | 70,000 | -66.7% | 0.00% | 0.0% |
| Q2 2019 | $2,541,000 | – | 210,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |